Literature DB >> 7460239

Platelet survival and the development of coronary artery disease in the young adult: effects of cigarette smoking, strong family history and medical therapy.

V Fuster, J H Chesebro, R L Frye, L R Elveback.   

Abstract

Cigarette smoking or a strong family history of coronary disease was present in 46 of 50 symptomatic patients with coronary artery disease who were younger than 50 years of age. We recorded a shortened platelet survival half-life (less than 92 hours) with 51Cr in 60% of these patients, in 56% of apparently normal persons of the same age who smoked or had a strong family history of coronary disease, and in only 14% of normal persons who did not smoke and had no family history (p less than 0.01). Lengthening of the shortened platelet survival toward normal occurred in coronary patients given dipyridamole plus aspirin and in apparently normal smokers who discontinued smoking (p less than 0.01). The study suggests a possible relationship among cigarette smoking, strong family history of coronary disease and platelet activation in the process of coronary atherogenesis in the young adult.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7460239     DOI: 10.1161/01.cir.63.3.546

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  23 in total

1.  Acute Coronary Syndromes: Molecular Basis for Cardiac Risk Factors.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

Review 2.  Myocardial infarction in patients with normal coronary arteries: proposed pathogenesis and predisposing risk factors.

Authors:  S P Pinney; L E Rabbani
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

Review 3.  Comprehensive review of cardiovascular toxicity of drugs and related agents.

Authors:  Přemysl Mladěnka; Lenka Applová; Jiří Patočka; Vera Marisa Costa; Fernando Remiao; Jana Pourová; Aleš Mladěnka; Jana Karlíčková; Luděk Jahodář; Marie Vopršalová; Kurt J Varner; Martin Štěrba
Journal:  Med Res Rev       Date:  2018-01-05       Impact factor: 12.944

4.  The central role of platelet activation in determining the severity of acute coronary syndromes.

Authors:  S Kennon; C P Price; P G Mills; M Macey; J Cooper; H Clarke; A D Timmis
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

Review 5.  Vessel wall-related risk factors in acute vascular events.

Authors:  L Badimon; J J Badimon; M Cohen; J H Chesebro; V Fuster
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 6.  The role of cigarettes and nicotine in the onset and treatment of ulcerative colitis.

Authors:  J Birtwistle
Journal:  Postgrad Med J       Date:  1996-12       Impact factor: 2.401

Review 7.  Impact of Smoking on the Atrial Substrate Characteristics in Patients with Atrial Fibrillation.

Authors:  Ta-Chuan Tuan; Shih-Lin Chang; Shih-Ann Chen
Journal:  J Atr Fibrillation       Date:  2008-09-16

8.  Treatment with cerivastatin in primary mixed hyperlipidemia induces changes in platelet aggregation and coagulation system components.

Authors:  A Ugur Ural; M Ilker Yilmaz; Ferit Avcu; Atilla Yalcin
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

9.  High mean platelet volume after myocardial infarction: is it due to consumption of small platelets?

Authors:  R Sewell; R M Ibbotson; R Phillips; P Carson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-08

10.  Cardiovascular risk factors and clinical presentation in acute coronary syndromes.

Authors:  A Rosengren; L Wallentin; M Simoons; A K Gitt; S Behar; A Battler; D Hasdai
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.